PTGX insider trading
CIK 1377121Protagonist Therapeutics, Inc: insider trade history from SEC Form 4 filings.
PTGX insider activity at a glance
FilingIQ tracks 341 insider transactions for PTGX in filings since Aug 16, 2016. The most recent transaction is dated Nov 19, 2026. They were reported by 22 insiders.
Across the full history, 13 open-market purchases
and 128 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest PTGX Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Tickers with similar insider activity
Ranked next to PTGX by Form 4 lines in the last 90 days, the number on each card.
13F funds holding PTGX
For the quarter ended Sep 30, 2026, 385 institutional managers reported a PTGX position on SEC Form 13F. The largest positions among the funds profiled on FilingIQ:
Frequently asked
- How many insider trades does FilingIQ track for PTGX?
- FilingIQ tracks 341 Form 4 insider transactions for PTGX (Protagonist Therapeutics, Inc), covering filings from Aug 16, 2016 onwards. 15 of those are dated within the last 90 days.
- Are PTGX insiders net buyers or net sellers?
- Across the full Form 4 history for PTGX, 13 transactions (4%) were open-market purchases and 128 (38%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does PTGX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- How many institutions report holding PTGX?
- For the quarter ended Sep 30, 2026, 385 institutional managers reported a PTGX position on SEC Form 13F. Investment managers with discretion over $100 million or more in 13(f) securities, mostly US-listed stocks, file a Form 13F within 45 days of each quarter end.
Methodology & sources
Every PTGX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.